SOUTH SAN FRANCISCO, CA--(Marketwire - December 19, 2007) - Theravance, Inc. (NASDAQ: THRX) announced today the appointment of Mathai Mammen, M.D., Ph.D., as Senior Vice President, Research, effective January 4, 2008. Dr. Mammen will report directly to Rick E Winningham, Chief Executive Officer. In this role, he will be responsible for the company’s research strategy and drug discovery activities. He succeeds Dr. Patrick Humphrey, who is retiring but will remain an advisor to the company.
